Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q2 2017 · 10-Q
Revenue$504.67M$504.67M−2.3% vs Q2 2016 Net Income$5.00M$5.00M−69.9% vs Q2 2016 EPS Diluted$0.17$0.17−69.6% vs Q2 2016 Gross Profit$273,400,000−2.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$62,500,000−19.0% Free Cash Flowderived$36,881,000−19.1% Margins · derivedGross margin54.2%−0.0 pt vs Q2 2016
Operating margin-0.3%−5.5 pt vs Q2 2016
Net margin1.0%−2.2 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 7, 2017 · 38 d after period end